Specifications tableSubject area*Environmental Science*More specific subject area*Air quality, particulate matter, toxicology and health*Type of data*Table*How data was acquired*Data acquired by literature search and normalization of data from different exposure protocols based on a model that calculates concentration, inhalation rates and particulate matter exposure dose. The selection filters applied to build the dataset were: published works and data were published in 2017, in the English language, and were referenced in indexed journals (with editorial board, peer reviewed and included in Clarivate Analytics Journal Citation Reports). Also, the papers selected were based on mice and/or rat models, and the protocol exposed the respiratory tract to PM to study the health effects in one or more specific endpoints (respiratory tract, pulmonary and extra-pulmonary). Given these conditions, a search string was used to query PubMed Particularly, the following keywords were used: (particulate matter) AND (mice or mouse or rats or rat) AND (inhalation or instillation). Apart from the most recent articles published in 2017, we also included seminal papers from previous years.*Data format*Calculated and analysed*Experimental factors*Data were compiled from experimental design description from 75 different research articles (155 toxicological experiments)*Experimental features*We used a model to calculate inhalation rates, concentrations and PM exposure dose from 155 different toxicological experiments*Data source location*Vila Velha, Brazil, Universidade Vila Velha*Data accessibility*Data is provided with this article*Related research articleF. Curbani, F.O. Busato, M.M. Nascimento, D.N. Olivieri, C.E. Tadokoro, Inhale, exhale: why particulate matter exposure in animal models are so acute? Environmental Pollution. In Press [@bib1]**Value of the data**•The data is valuable to researchers interested in understanding the health effects of particulate matter by means of experimental studies with animal models.•The variables described are the concentration, dose, and inhalation rate used in different toxicological experiments with mice and rats performed by instillation and inhalation.•This data consists of a normalized collection of different experimental protocols of exposure to particulate matter that is useful for comparing experiments findings.•Normalization of the exposure variables allows the ability to compare results to reported environmental particulate matter concentrations.•Comparisons between the results from different exposure protocols and comparison with environmental concentrations allows for a better understanding of the exposure protocols that can improve experimental design of future studies.

1. Data {#sec1}
=======

The data consists of a list of selected articles where particulate matter (PM) exposure experiments were performed in mice and rats. From each of source article, we extracted the objectives of each study as related by the original authors ([Table 1](#tbl1){ref-type="table"}). The compiled data and normalization were processed with an equation based on a PM dosimetry model considering physiological breathing parameters and PM inhaled fraction (inhalability) in mice and rats ([Table 2](#tbl2){ref-type="table"}). From the collection of selected articles, the data provides a list of reviewed experiments, methods and characteristics of each exposure protocol, including concentrations, doses and PM inhalation rates normalized by a PM dose model ([Table 3](#tbl3){ref-type="table"}), and a summary of the variables from different PM exposure protocols in mice and rats ([Table 4](#tbl4){ref-type="table"}).Table 1List of articles from PubMed where PM exposure was performed in mice and rats and the objectives of each study as related by the authors. The dataset includes 30 articles published in 2017 and 45 articles published in previous years.Table 1Exposure protocolsObjectivesAuthorsCAP inhalationThe objective of this study was to determine whether short-term exposures to concentrated ambient particles alter the morphology of small pulmonary arteries in normal rats and rats with chronic bronchitis (CB).[@bib15]CAP inhalationOur objective was to provide experimental plausibility for epidemiological observations by testing the hypothesis that exposure to particulate matter with nominal mean aerodynamic diameters of 2.5 μm or less (PM~2.5~) during discrete periods of pregnancy results in preterm birth (PTB) and low birth weight (LBW).[@bib16]CAP inhalationThe objectives of the present study were: 1) to determine whether acute exposure to low levels of particles promotes measurable acute systemic and cardiopulmonary effects; and 2) to assess if the magnitude of the observed alterations is influenced by season.[@bib17]CAP inhalationThis study investigates the effects of inhaled ammonium sulphate, which is a major compound of inorganic air pollutants in PM~2.5~, on adult neurogenesis in aged Sprague-Dawley rats.[@bib18]CAP inhalationThe hypothesis tested was that older animals would exhibit more severe pulmonary inflammation and haematological changes following the CAP exposure when compared to young, normal animals.[@bib19]CAP inhalationWe evaluated the effects of air pollution on the adrenal cortex using female mice. One group was conditioned daily in a chamber with exposure to particulate matter.[@bib20]CAP inhalationMice were used to investigate the effects of iRhom2 on PM~2.5~-induced hepatic dyslipidaemia.[@bib21]CAP inhalationThe present work was designed to: (i) determine whether short-term exposure to concentrated air particles causes pulmonary inflammation in normal rats; (ii) characterize the component(s) of CAP that are significantly associated with the development of the inflammatory reaction; and (iii) define the induction of mediators and other pathophysiological response elements of the lung with CAP exposure.[@bib22]CAP inhalationThe aim of this study was to investigate the mechanism by which PM~2.5~ influences the Notch signalling pathway leading to worsening immune disorder and accelerating chronic obstructive pulmonary disease (COPD) development.[@bib23]CAP inhalationWe investigated the roles of T-helper (Th)1--Th2 cytokines and nasal remodelling after ambient PM~2.5~ exposure in a rat model of allergic rhinitis.[@bib13]CAP inhalationWe investigated the in vivo effects of PM~2.5~ exposure on the inflammatory response, oxidative stress, the enzyme activities of Na + K + -ATPase and Ca2+-ATPase, and the morphology and function of mitochondria in the nasal mucosa of rats.[@bib24]CAP inhalationTo evaluate the ability of particulate air pollution to promote oxidative stress and tissue damage in vivo, we studied a rat model of short-term exposure to concentrated ambient particles.[@bib25]CAP inhalationWe conducted a study to compare the inflammatory response of the lung to instilled versus inhaled particles.[@bib26]CAP inhalationWe have investigated whether long-term inhalation exposure to diesel engine exhaust, a dominant contributor to particulate air pollution in urban environments, can aggravate Alzheimer\'s Disease (AD)-like effects in female 5X Familial AD (5XFAD) mice and their wild-type female littermates.[@bib27]CAP inhalationThe aim of this study was to identify the impact of titanium dioxide (TiO~2~) nanoparticles on inflammasome in a mouse model of allergic asthma.[@bib28]CAP inhalationTo test the impact of chronic airborne particulate matter exposure on the upper respiratory system in vivo.[@bib12]CAP inhalationTo determine whether oxidants are implicated in PM-dependent lung inflammation, we tested the ability of N-acetylcysteine (NAC) to prevent lung inflammation in a rat model of short-term exposure to concentrated ambient particles.[@bib29]CAP inhalationThe objectives of this study were (1) to determine whether short-term exposures to concentrated air particles cause pulmonary inflammation in normal rats and rats with chronic bronchitis (CB); (2) to identify the site within the lung parenchyma where CAP-induced inflammation occurs; and (3) to characterize the component(s) of CAP that is significantly associated with the development of the inflammatory reaction.[@bib30]CAP inhalationThe objective was to identify and quantify estrogenic receptor-b (ERb), aryl hydrocarbon receptor (AhR), the cytochrome P450 enzymes CYP1A1, 1A2, 1B1, and mucus profile in the nasal epithelium of mice[@bib31]CAP inhalationThis study evaluated the inflammatory differences in BALB/c mouse males and females in three phases of the estrous cycle that were exposed to ambient air or concentrated ambient particles.[@bib32]CAP inhalationThe purpose of this study was to determine the respiratory effects of inhaled ultrafine iron particles in rats.[@bib33]CAP inhalation and intranasal instillationWe compared the physiological consequences of short-term exposure to diesel exhaust via inhalation to those due to exposure to the same diesel exhaust particles suspended in solution and delivered intranasally.[@bib34]CAP inhalation and intratracheal instillationThe present study was designed to compare intratracheal instillation to inhalation exposure derived health endpoints of acute lung toxicity in the rat that relate to homologous clinical outcomes that have been reported with ambient PM using a well characterized model emission PM, which would have demonstrable and relevant effects at low lung doses by both methods.[@bib35]CAP inhalation and intratracheal instillationWe used pharmacological strategies to determine whether oxidants are implicated in PM-dependent cardiac dysfunction and whether PM-induced increase in autonomic stimulation on the heart mediates cardiac oxidative stress and toxicity.[@bib36]EAP inhalationThe aim of this study was to verify the effects of ambient air pollution of São Paulo City on coronary of healthy non-isogenic Swiss mice, chronically exposed since birth until adulthood.[@bib37]EAP inhalationWe investigated effects of chronic exposure (2 months) to ambient levels of particulate matter on development of protease-induced emphysema and pulmonary remodelling in mice.[@bib38]EAP inhalationThe aim of the present study was to analyse the effects of air pollution in the city of São Paulo on mouse female fertility.[@bib39]EAP inhalationThe present study was conducted to a) determine whether short-term exposure to ambient levels of particulate air pollution from vehicles elicits inflammatory responses and lipid peroxidation in rat lungs, and b) determine if intermittent short-term exposures induce some degree of tolerance.[@bib40]Intranasal instillationTo investigate how the combination of soybean allergens and diesel exhaust particles (DEP) can affect the induction or exacerbation of asthma in a murine model.[@bib41]Intranasal instillationWe hypothesized that sub-chronic exposure to PM~2.5~ in HFD-treated mice, susceptible to type 2 diabetes mellitus (T2DM), would also be able to change nutrient metabolism-related tissues (NMRT) cellular antioxidant defense, and the balance between intracellular 70-kDa heat shock proteins (iHSP70) and extracellular 72-kDa heat shock proteins (eHSP72) contents expressed as \[eHSP72\]/\[iHSP70\] ratio, predisposing for a major risk of cellular damage and development T2DM.[@bib42]Intranasal instillationWe assessed the effects of Bufei Huoxue (BFHX) capsules on PM~2.5~-induced pulmonary inflammation and the underlying mechanisms of action.[@bib43]Intranasal instillationThis study aimed to investigate the effects of winter and spring particulate matter on airway inflammation and allergies in a mouse asthma model.[@bib44]Intranasal instillationThis study aimed to investigate the effects of AD on the early stage of antigen sensitization using a mouse model of asthma, as well as the role of leukotrienes (LTs) in antigen-induced airway inflammation potentiated by AD particles.[@bib45]Intranasal instillationIn order to assess the relationship between PM~2.5~ exposure and autism spectrum disorder, neonatal male Sprague--Dawley rats were chosen and exposed to PM~2.5~ by intranasal instillation.[@bib46]Intranasal instillationThe aim of this work was to evaluate the time changes of systemic markers of oxidative stress and inflammation, after an acute exposure to Residual Oil Fly Ash (ROFA).[@bib47]Intranasal instillationOur objective was to analyse air PM from downtown Buenos Aires (UAP-BA) and evaluate its biological impact on normal airways. We studied the inflammatory response to intranasal instillation of UAP-BA in a short-term-exposure mouse model.[@bib48]Intranasal instillationWe studied lung responses to low doses of urban air particulate matter from Buenos Aires (UAP-BA), with special emphasis on oxidative balance.[@bib49]Intranasal instillationThe objective was to verify how these organic compartments respond to increasing concentrations of particles of known elemental composition.[@bib50]Intranasal instillationThe aim of this study was to analyse in vivo the acute biological impact of two environmental particles, urban air particles from Buenos Aires and Residual Oil Fly Ash, on the cardiorespiratory system of middle-aged mice, evaluating oxidative metabolism and inflammation.[@bib51]Intranasal instillationWe tested the hypothesis that a single acute exposure to low doses of fine particulate matter (PM~2.5~) may induce functional and histological lung changes and unchain inflammatory and oxidative stress processes. PM~2.5~ was collected from the urban area of São Paulo city during 24 h and underwent analysis for elements and polycyclic aromatic hydrocarbon contents.[@bib52]Intranasal instillationThe aim of this study was to evaluate the effects of subchronic exposure to low doses of diesel exhaust particles (DEP) instilled in the respiratory tract of mice.[@bib53]Intranasal instillationThe therapeutic effects of stemonine on mice with PM~2.5~-induced COPD were investigated in the present study.[@bib54]Intranasal instillationTo test our hypothesis that cardiovascular diseases associated with sulphur dioxide (SO~2~), nitrogen dioxide (NO~2~), or PM~2.5~ exposure are the result of increased heart rate (HR), decreased blood pressure (BP) and enhanced systemic inflammation.[@bib55]Intratracheal instillationThe aim of the present study was to evaluate the effects of PM~10~ on electrocardiogram (ECG) parameters, blood pressure, lipid peroxidation (MDA), xanthine oxidase, and antioxidant enzyme in healthy rats and also to examine the protective effects of vanillic acid (VA) in this respect.[@bib56]Intratracheal instillationThis study aims to observe whether the combined treatment with vitamin E (vit E) and omega-3 polyunsaturated fatty acids (U-3 FA) could prevent the fine particulate matter (PM~2.5~)-induced cardiovascular injury through alleviating inflammation and oxidative stress.[@bib57]Intratracheal instillationThe purpose of our study is to investigate PM~10~ sum effects on lungs and extra pulmonary tissues. The aim of this study is to disclose the pulmonary short-term effects and extra-pulmonary translocation of PM~10~ sum collected in Milano urban centre.[@bib58]Intratracheal instillationTo assess susceptibility to lung infection following coexposure to particulate matter.[@bib59]Intratracheal instillationIn this study, we evaluated the primary oxidative stress produced in the lung by crystalline silica (SiO~2~) in the early phase after SiO~2~ exposure. The aim of this study is to understand the crystalline SiO~2~-induced pulmonary oxidative stress in the early phase.[@bib60]Intratracheal instillationThis study was conducted to investigate the possible protective effects and mechanisms of aspirin, Vitamin C, Vitamin E, or ozone on fertility in female mice treated with PM~2.5~.[@bib61]Intratracheal instillationWe investigated the association of the chemical composition and sources of urban air fine (PM2.5−0.2) and coarse (PM10−2.5) particulate samples with the inflammatory activity in the mouse lung.[@bib62]Intratracheal instillationThis study was undertaken to clarify the effects of Asian sand dust on lung eosinophilia in mice immunized beforehand by ovalbumin (OVA).[@bib63]Intratracheal instillationIn the present study, urban PM2.5 and coarse particulate matter (CPM) collected during haze events of Northeast China in the winter season were used. The exacerbating effects of PM~2.5~ and CPM on OVA-induced allergic inflammation in murine lungs were compared to clarify the role of the chemicals and microbial materials in the two types of PM.[@bib64]Intratracheal instillationIn order to further understand the roles of microRNAs in regulating the imbalance of T-helper 1 (Th1)/T-helper 2 (Th2) differentiation triggered by PM~2.5~.[@bib65]Intratracheal instillationThe current study aimed to evaluate the effects of size-fractioned PM on lung immune responses in healthy BALB/c mice.[@bib66]Intratracheal instillationwe investigated whether exposure to PM~2.5~, a PM with an aerodynamic diameter of less than 2.5 mm, enhances inflammation-related toxicity in the human respiratory system through activation of the epidermal growth factor receptor (EGFR) signalling pathway.[@bib67]Intratracheal instillationThis study investigated the effect of acute respiratory exposure to PM on eyes, as induction of retinal thickening.[@bib68]Intratracheal instillationWe investigated whether PM instillation in the airway could alter the course of acute lung injury, using a murine model with experimental lung injury induced by intratracheal lipopolysaccharide (LPS) challenge.[@bib69]Intratracheal instillationThe objective is to investigate the influence of PM~2.5~ exposure on peripheral blood lymphocyte subsets in pregnant mice and the antagonism of quercetin on adverse effects induced by PM~2.5~ exposure.[@bib70]Intratracheal instillationWe intend to investigate the toxic effects of PM~2.5~ during summer and winter on reproductive cells and tissues and focus on endoplasmic reticulum stress (ERS) to illustrate the possible molecular mechanisms.[@bib71]Intratracheal instillationWe wished to investigate the impact of PM~2.5~ on placenta and prenatal outcomes and its related mechanisms in a rat model.[@bib72]Intratracheal instillationWe assessed the effect of prolonged exposure to diesel exhaust particles (DEP) on chronic renal failure induced by adenine, which is known to involve inflammation and oxidative stress.[@bib73]Intratracheal instillationTo evaluate the effect of airborne particulate matter 2.5 (PM~2.5~) in winter on airway inflammation, water-soluble supernatant (Sup) and water-insoluble precipitate (Pre) in PM~2.5~ were inoculated in NC/Nga mice with high sensitivity to mite allergens.[@bib74]Intratracheal instillationTo evaluate the allergic effect of airborne particulate matter (PM) on the airway, separated soluble supernatant (Sup) and insoluble precipitate (Pre) in suspended PM were inoculated into NC/Nga mice with a high sensitivity for mite allergens.[@bib75]Intratracheal instillationThe allergic inflammatory effects of particulate matter PM~2.5~, collected with the cyclone system in Yokohama city in Japan, were investigated in NC/Nga mice.[@bib2]Intratracheal instillationWe aimed to explore the toxic mechanisms of cardiovascular injuries induced by ambient fine particulate matter (PM~2.5~) in atherosclerotic-susceptible ApoE−/− mice.[@bib76]Intratracheal instillationWe investigated by the optical microscopy some cytological characteristics of the bronchoalveolar lavage fluid cell population 24 h after intratracheal instillation of microscale manganese dioxide (MnO~2~) and barium chromate (BaCrO~4~) particles (separately or together at two different doses) into the lungs of Wistar rats.[@bib77]Intratracheal instillationThe aim of this study is to disclose short-term adverse effects on respiratory and cardiovascular systems induced by winter fine particles exposure.[@bib78]Intratracheal instillationThe immune cells, including pulmonary macrophages of Sprague--Dawley (SD) rats and Raw 264.7 cells, were applied to further investigate the effect of PM~2.5~ on cell autophagy of macrophages, thus clarified the possible molecular mechanism of immunotoxicity caused by PM~2.5~.[@bib79]Intratracheal instillationWe hypothesized that mechanisms independent of inflammation contribute to accelerated thrombus formation following exposure to diesel exhaust particles (DEP).[@bib80]Intratracheal instillationThe primary objective of this study was to provide insights on the factors affecting the toxicological potency of exhaust PM emitted from different light-duty vehicles. This study presents different research techniques linked together to improve our understanding of the particulate matter (PM) impacts on health. The study develops conceptual dose--response functions for the different vehicle configurations.[@bib81]Intratracheal instillationIn order to understand the comprehensive pulmonary response to PM~2.5~ stress, a non-targeted high-throughput metabolomics strategy was adopted to characterize the overall metabolic changes and relevant toxicological pathways.[@bib82]Intratracheal instillationWe constructed a rat model to investigate the roles of autophagy in blood-testis barrier (BTB) toxicity induced by PM~2.5~. Sprague--Dawley rats were developmentally exposed to normal saline (NS) or PM~2.5~ with the doses via intratracheal instillation.[@bib83]Intratracheal instillationShort- and long-term exposure to particulate matter (PM) 2.5 instigates adverse health effect upon the cardiovascular system. We demonstrated that Wuhan PM~2.5~ exposure induced elevation of systemic Angiotensin II (ANGII) and local angiotensin-converting enzyme (ACE)/ANGII/ANGII type 1 receptor (AT1R) axis activation and the subsequent oxidative stress and proinflammatory responses in the vascular endothelium.[@bib84]Intratracheal instillationIn order to investigate the mechanisms in PM~2.5~ toxicity, we explored the endogenous metabolic changes and possible influenced metabolic pathways in rats after intratracheal instillation of PM~2.5~.[@bib85]Intratracheal instillationThe aim of this study was to evaluate the inflammatory response to SiO~2~ nanoparticles using in vivo test systems.[@bib86][^1]Table 2Physiological breathing parameters and PM inhaled fraction (inhalability) in mice and rats.Table 2VariablesMouseRatAuthorsBody mass, *Bw* (kg)0.0250.250[@bib6]Tidal volume, *V*~*t*~ (mL)0.2182.100[@bib7]Minute volume, *V*~*m*~ (mL/min)60.4252.0[@bib7]Breathing frequency, *f* (min^−1^)277120[@bib7]Inhalability, *I* (%) PM~1~8892[@bib4] PM~2.5~6775[@bib4] PM~10~2025[@bib4]Table 3List of experiments where PM exposure was performed in mice and rats, with methods and characteristics of each procedure. The dataset includes 30 articles published in 2017 and 45 articles published in previous years.Table 3Exposure methodPM sizeAnimal modelEquivalent atmospheric concentration (μg/m^3^)Time of one exposure event (h)Number of exposure eventsTotal exposure time (h)Inhaled dose per event (μg/kg *Bw*)PM inhalation rate (μg/kg *Bw*/h)AuthorsEAP inhalationPM~2.5~Mouse18.128801288012619.24.4[@bib37]PM~10~Rat22.06165.00.8[@bib40]PM~10~Mouse33.92460144058.92.5[@bib38]PM~10~Rat34.06167.71.3[@bib40]PM~10~Mouse48.924120288085.03.5[@bib39]PM~10~Rat99.2542018.73.7[@bib40]PM~10~Rat112.42012085.04.2[@bib40]PM~10~Rat138.620120104.85.2[@bib40]PM~10~Rat224.761651.08.5[@bib40]CAP inhalationPM~1~Mouse50.023631.915.9[@bib28]PM~1~Rat57.0631847.67.9[@bib33]PM~1~Rat90.0631875.112.5[@bib33]PM~2.5~Mouse60.968048088.714.8[@bib12]PM~2.5~Mouse101.56120720147.824.6[@bib21]PM~2.5~Mouse113.4617102165.227.5[@bib16]PM~2.5~Rat126.1531571.514.3[@bib15]PM~2.5~Rat126.1531571.514.3[@bib30]PM~2.5~Mouse163.8617102238.639.8[@bib16]PM~2.5~Rat170.7531596.819.4[@bib15]PM~2.5~Rat170.7531596.819.4[@bib30]PM~2.5~Rat187.15315106.121.2[@bib15]PM~2.5~Rat187.15315106.121.2[@bib30]PM~2.5~Rat200.03309068.022.7[@bib24]PM~2.5~Rat200.03309068.022.7[@bib13]PM~2.5~Mouse203.016649.349.3[@bib17]PM~2.5~Mouse203.316649.349.3[@bib17]PM~2.5~Rat262.25315148.729.7[@bib22]PM~2.5~Rat267.35315151.630.3[@bib15]PM~2.5~Rat267.35315151.630.3[@bib30]PM~2.5~Rat300.011134.034.0[@bib25]PM~2.5~Rat300.0313102.134.0[@bib25]PM~2.5~Rat300.0515170.134.0[@bib25]PM~2.5~Rat300.75315170.534.1[@bib15]PM~2.5~Rat300.75315170.534.1[@bib30]PM~2.5~Rat400.06318272.245.4[@bib19]PM~2.5~Rat481.05315272.754.5[@bib15]PM~2.5~Rat481.05315272.754.5[@bib30]PM~2.5~Rat595.022856134.967.5[@bib18]PM~2.5~Mouse600.011212145.7145.7[@bib32]PM~2.5~Mouse600.012121145.7145.7[@bib20]PM~2.5~Mouse600.011212145.7145.7[@bib31]PM~2.5~Rat700.0515396.979.4[@bib36]PM~2.5~Mouse770.019090186.9186.9[@bib23]PM~2.5~Mouse950.0615901383.7230.6[@bib27]PM~2.5~Mouse950.06653901383.7230.6[@bib27]PM~2.5~Rat1000.033090340.2113.4[@bib24]PM~2.5~Rat1000.033090340.2113.4[@bib13]PM~2.5~Rat1228.051050696.3139.3[@bib29]PM~2.5~Rat2000.033090680.4226.8[@bib13]PM~2.5~Rat3000.0330901020.6340.2[@bib24]PM~2.5~Rat12000.06168164.81360.8[@bib35]PM~2.5~Mouse20000.028169710.14855.0[@bib34]PM~2.5~Mouse30000.0281614565.17282.6[@bib34]PM~10~Rat100.062012022.73.8[@bib26]PM~10~Rat1000.0620120226.837.8[@bib26]PM~10~Rat10000.06201202268.0378.0[@bib26]Intranasal instillationPM~2.5~Mouse700.3199170.0170.0[@bib49]PM~2.5~Mouse700.3199170.0170.0[@bib48]PM~2.5~Mouse823.9111200.0200.0[@bib52]PM~2.5~Mouse823.918484200.0200.0[@bib42]PM~2.5~Mouse2471.7111600.0600.0[@bib52]PM~2.5~Mouse4119.41111000.01000.0[@bib51]PM~2.5~Mouse4119.41111000.01000.0[@bib47]PM~2.5~Mouse4119.41771000.01000.0[@bib55]PM~2.5~Mouse4943.3121211200.01200.0[@bib53]PM~2.5~Mouse4943.3142421200.01200.0[@bib53]PM~2.5~Mouse13841.31883360.03360.0[@bib34]PM~2.5~Mouse20762.01885040.05040.0[@bib34]PM~2.5~Rat17636.7114142000.02000.0[@bib46]PM~2.5~Mouse24716.61996000.06000.0[@bib41]PM~2.5~Mouse41194.41282810000.010000.0[@bib55]PM~2.5~Mouse164777.414440000.040000.0[@bib43]PM~2.5~Mouse164777.417740000.040000.0[@bib54]PM~2.5~Rat176366.81141420000.020000.0[@bib46]PM~10~Mouse55.21114.04.0[@bib50]PM~10~Mouse552.011140.040.0[@bib50]PM~10~Mouse5520.0111400.0400.0[@bib50]PM~10~Mouse55200.41554000.04000.0[@bib44]PM~10~Mouse55200.41554000.04000.0[@bib45]Intratracheal instillationPM~1~Mouse690.0111220.0220.0[@bib81]PM~1~Mouse1254.6111400.0400.0[@bib81]PM~1~Mouse1380.0111440.0440.0[@bib81]PM~1~Mouse1505.5111480.0480.0[@bib81]PM~1~Mouse1568.2177500.0500.0[@bib73]PM~1~Mouse2509.1111800.0800.0[@bib81]PM~1~Mouse3010.9111960.0960.0[@bib81]PM~1~Mouse4390.91221400.01400.0[@bib66]PM~1~Mouse12545.61224000.04000.0[@bib66]PM~1~Mouse31363.912210000.010000.0[@bib66]PM~1~Rat35944.31115000.05000.0[@bib86]PM~2.5~Rat278.311131.631.6[@bib59]PM~2.5~Rat705.511180.080.0[@bib68]PM~2.5~Rat1763.7111200.0200.0[@bib59]PM~2.5~Rat1763.7111200.0200.0[@bib59]PM~2.5~Rat1763.712020200.0200.0[@bib71]PM~2.5~Rat1763.712020200.0200.0[@bib79]PM~2.5~Rat2645.512020300.0300.0[@bib71]PM~2.5~Rat2645.512020300.0300.0[@bib79]PM~2.5~Mouse3295.5144800.0800.0[@bib67]PM~2.5~Mouse3295.5177800.0800.0[@bib69]PM~2.5~Rat3527.3111400.0400.0[@bib59]PM~2.5~Rat3527.3111400.0400.0[@bib60]PM~2.5~Rat3880.1111440.0440.0[@bib35]PM~2.5~Rat5291.012020600.0600.0[@bib71]PM~2.5~Rat5291.012020600.0600.0[@bib79]PM~2.5~Mouse5767.21221400.01400.0[@bib66]PM~2.5~Rat8218.7111932.0932.0[@bib59]PM~2.5~Rat8849.71111003.61003.6[@bib59]PM~2.5~Rat9982.41111132.01132.0[@bib59]PM~2.5~Mouse10298.61112500.02500.0[@bib65]PM~2.5~Mouse12358.31333000.03000.0[@bib76]PM~2.5~Rat13227.5120201500.01500.0[@bib71]PM~2.5~Rat13227.5120201500.01500.0[@bib79]PM~2.5~Rat13227.51331500.01500.0[@bib84]PM~2.5~Rat15873.0110101800.01800.0[@bib85]PM~2.5~Mouse16477.71444000.04000.0[@bib64]PM~2.5~Mouse16477.71224000.04000.0[@bib66]PM~2.5~Mouse16477.71334000.04000.0[@bib78]PM~2.5~Rat17636.71112000.02000.0[@bib80]PM~2.5~Rat23809.5120202700.02700.0[@bib71]PM~2.5~Rat23809.5120202700.02700.0[@bib79]PM~2.5~Rat26455.01113000.03000.0[@bib36]PM~2.5~Mouse27023.51446560.06560.0[@bib67]PM~2.5~Mouse32955.51668000.08000.0[@bib75]PM~2.5~Mouse32955.51668000.08000.0[@bib2]PM~2.5~Mouse32955.51668000.08000.0[@bib74]PM~2.5~Mouse41194.41111110000.010000.0[@bib61]PM~2.5~Mouse41194.411110000.010000.0[@bib62]PM~2.5~Mouse41194.411110000.010000.0[@bib65]PM~2.5~Mouse41194.412210000.010000.0[@bib66]PM~2.5~Mouse41194.413310000.010000.0[@bib76]PM~2.5~Rat47619.0110105400.05400.0[@bib85]PM~2.5~Mouse61791.515515000.015000.0[@bib70]PM~2.5~Rat79365.1149499000.09000.0[@bib83]PM~2.5~Mouse82388.711120000.020000.0[@bib65]PM~2.5~Rat88183.411110000.010000.0[@bib57]PM~2.5~Rat88183.411110000.010000.0[@bib77]PM~2.5~Mouse123583.113330000.030000.0[@bib76]PM~2.5~Rat132275.112215000.015000.0[@bib72]PM~2.5~Rat142857.11101016200.016200.0[@bib85]PM~2.5~Rat176366.811120000.020000.0[@bib77]PM~2.5~Rat211640.21494924000.024000.0[@bib83]PM~2.5~Rat220458.61121225000.025000.0[@bib82]PM~10~Rat5291.0111200.0200.0[@bib26]PM~10~Rat13227.5111500.0500.0[@bib56]PM~10~Mouse19320.21221400.01400.0[@bib66]PM~10~Rat21164.0111800.0800.0[@bib26]PM~10~Mouse55200.41114000.04000.0[@bib58]PM~10~Mouse55200.41224000.04000.0[@bib66]PM~10~Rat66137.61112500.02500.0[@bib56]PM~10~Rat79365.11113000.03000.0[@bib26]PM~10~Mouse110400.9118000.08000.0[@bib63]PM~10~Rat132275.11115000.05000.0[@bib56]PM~10~Mouse138001.111110000.010000.0[@bib62]PM~10~Mouse138001.112210000.010000.0[@bib66][^2]Table 4Summary of exposure characteristics from different PM exposure protocols in mice and rats.Table 4Exposure MethodPM sizenConcentration (μg/m^3^)PM inhalation rate (μg/kg *Bw*/h)MeanSEMRangeMeanSEMRangeEAP inhalationPM~2.5~11.8 × 10^1^4.4 × 10^0^PM~10~88.9 × 10^1^2.5 × 10^1^2.2 × 10^1^--2.2 × 10^2^3.7 × 10^0^9.0 × 10^1^8.0 × 10^−1^ - 8.5 × 10^0^CAP inhalationPM~1~36.6 × 10^1^1.2 × 10^1^5.0 × 10^1^--9.0 × 10^1^1.2 × 10^1^2.3 × 10^0^7.9 × 10^0^--1.6 × 10^1^PM~2.5~412.0 × 10^3^8.9 × 10^2^6.1 × 10^1^--3.0 × 10^4^4.0 × 10^2^2.1 × 10^2^1.4 × 10^1^--7.3 × 10^3^PM~10~33.7 × 10^3^3.2 × 10^3^1.0 × 10^2^--1.0 × 10^4^1.4 × 10^2^1.2 × 10^2^3.8 × 10^0^--3.8 × 10^2^Intranasal instillationPM~2.5~183.6 × 10^4^1.5 × 10^4^7.0 × 10^2^--1.8 × 10^5^7.8 × 10^3^3.0 × 10^3^1.7 × 10^2^--4.0 × 10^4^PM~10~52.3 × 10^4^1.3 × 10^4^5.5 × 10^1^--5.5 × 10^4^1.7 × 10^3^9.5 × 10^2^4.0 × 10^0^--4.0 × 10^3^Intratracheal instillationPM~1~118.7 × 10^3^3.9 × 10^3^6.9 × 10^2^--3.6 × 10^4^2.2 × 10^3^9.2 × 10^2^2.2 × 10^2^--1.0 × 10^4^PM~2.5~533.9 × 10^4^7.3 × 10^3^2.8 × 10^2^--2.2 × 10^5^6.1 × 10^3^1.0 × 10^3^3.2 × 10^1^--3.0 × 10^3^PM~10~126.9 × 10^4^1.4 × 10^4^5.3 × 10^3^--1.4 × 10^5^4.1 × 10^3^1.0 × 10^3^2.0 × 10^2^--1.0 × 10^4^[^3]

2. Experimental design, materials, and methods {#sec2}
==============================================

2.1. Criteria for paper selection {#sec2.1}
---------------------------------

The published works included in our dataset were selected using the following criteria: papers were published in English, they were referenced in indexed journals (with editorial board, peer reviewed and included in Clarivate Analytics *Journal Citation Reports*), and they were published recently (in 2017). The selected papers were based on mice and/or rat models, and the protocol exposed the respiratory tract to PM in order to study the health effects at one or more specific endpoints (respiratory tract, pulmonary and extra-pulmonary). With these criteria, a search query was constructed for PubMed. Searches were performed using the following keywords: (particulate matter) AND (mice or mouse or rats or rat) AND (inhalation or instillation). Apart from the most recent articles published in 2017, we also included seminal papers from previous years.

From the PubMed timeline of the selected papers ([Fig. 1](#fig1){ref-type="fig"}), an increase can be observed in the number of publications indexed by the keywords "inhalation" and "instillation" with "inhalation" cited in more articles than "instillation". Such behaviour is similar over other years.Fig. 1PubMed timelines of two datasets considering the number of articles indexed by "inhalation" and "instillation" as keywords in combination with (particulate matter) AND (rat or rats or mouse or mice). The timeline begins at 1955 (first "inhalation" article found) and ends at 2017.Fig. 1

From the resulting group of articles, only those papers containing experimental impacts of environmental PM effects, as described in their material and methods sections, were included. Experiments that used total suspended particles or settleable particulate matter (six articles) and experiments carried out by oropharyngeal aspiration (four articles) were excluded. After applying the filtering criteria to the PubMed query results, 75 articles were selected, containing 155 different experiments.

Normalization of different experimental results to allow comparisons among doses and results.

One difficulty in comparing studies that use different exposure protocols is the way as PM amounts are reported. Studies using instillation protocols report the mass of administered PM (dose) at each exposure event and studies using inhalation, report PM concentration and exposure time. To compare data and results for methods having such intrinsic differences, we used an equation based on PM dosimetry models [@bib3], [@bib4], [@bib5]. This equation normalizes the administered PM dose (*D*), taking into account PM inhaled fraction (inhalability) as a function of the aerodynamic diameter (*d*~a~) [@bib3], [@bib4], [@bib5]. Thus, the following formula was defined:$$D = C \cdot Q \cdot t \cdot I$$

The parameters used in this formula are described below:

*D* = dose according to *d*~*a*~ (μg)

*C* = PM concentration (μg/m^3^)

*Q* = air inhalation flow (m^3^/min)

*t* = exposure time (min)

*I* = inhalability according to *d*~*a*~ (%)

The exposure dose varies according to the respiratory physiologic parameters of each species ([Table 1](#tbl1){ref-type="table"}), which are experimentally obtained or calculated by allometric models [@bib4], [@bib6], [@bib7]. The air inhalation flow (*Q*) is calculated from the ratio between the tidal volume (*V*~*T*~) and the inhalation time (*t*~*i*~) and indicates the inhaled air volume per unit of time [@bib8]. Assuming a ratio of 0.4/0.6 for inhalation versus exhalation times in mice and rats [@bib9], [@bib10], it is possible to estimate the *t*~*i*~ according to the respiration frequency (*f*) in mice and rats. We defined the PM inhaled dose as the PM mass that reaches the respiratory tract, i.e., it is the dose that can be inhaled, even if part of PM were deposited in the upper respiratory tract (URT). This definition is consistent with the concept of delivered dose, the amount of PM inhaled by the animal [@bib11].

This equation is not only useful for calculating the administered PM doses, but can also be used to normalize other quantities and to calculate the equivalent PM concentration (C), according to the instillation protocols (*C* = *D*/(*Q·t·I*)). For example, the PM inhalation rate (*IR*, μg/h) can be determined if we disregard exposure time (*t*). Moreover, both *D* and *IR* can be expressed in terms of the experimental animal body mass, and in these cases, two other indices are determined: specific dose (*D*~*BW*~) and specific inhalation rate (*IR*~*BW*~).

Since we have different exposure protocols, some considerations about the application of equation [(1)](#fd1){ref-type="disp-formula"} are necessary:

\(i\) Equation [(1)](#fd1){ref-type="disp-formula"} was used to establish the equivalence between protocols performed by instillation and inhalation. The protocols by instillation are performed after anaesthetics administration, which can change the physiological breathing parameters of the animals. However, equation [(1)](#fd1){ref-type="disp-formula"}, does not consider the effect of anaesthesia. Thus, the variations of the breathing parameters that could be caused by anaesthesia are not included in applying equation [(1)](#fd1){ref-type="disp-formula"}, designed to calculate the delivered dose by inhalation.

\(ii\) Physiological breathing parameters described in [Table 1](#tbl1){ref-type="table"} may present variations according to the different references. These parameters can vary between species, strains and even between individuals. However, within the limits of application of equation [(1)](#fd1){ref-type="disp-formula"}, we define the data acquisition referenced in recent publications developed by specialist researchers. At present, order of magnitude parameter estimation is the most relevant way to study different methods because the variations of PM exposure between methods are quite large and exceed orders of magnitude. Thus, variations in the physiological breathing parameters within the same order of magnitude can be assimilated without changing the conclusions of this study.

\(iii\) In instillation protocols, the PM is administered in a liquid media, while in the inhalation methods, the PM is dispersed in air. The distribution and deposition of PM in the respiratory tract is different when administered in liquid or in the air. It is known that intranasal instillation (INI), even in a liquid media, must pass the URT before reaching the LRT. However, considering the definition of inhaled dose previously mentioned, in this study, even if the deposition occurs in URT, we consider that the respiratory tract had contact with PM. Some studies included in our dataset, examined extra-pulmonary and systemic PM effects, including allergic responses in URT [@bib12], [@bib13]. In addition, instillation protocols introduce into airways types and quantities of particles that would not naturally reach there by inhalation. This may be one of the most relevant differences between exposure methods. Thus, inhalability was used as an important variable to calculate the equivalence between instillation and inhalation methods. As such, inhalability considers the difficulty of reaching the airways imposed by aerodynamic restrictions related to particle size [@bib3], [@bib14].

\(iv\) Finally, in some cases, few assumptions should be pre-determined to allow the calculation of *D* and *C*. In studies based on instillation, the amount of time spent to perform this procedure was 1 h. We assumed this time duration to calculate the dosage used. In fact, this duration is smaller than 1 h, probably minutes, but this would raise *D* and *C* to very excessive doses when compared with environmental concentrations measured around the world. In addition, we used a 1 h dose duration because most air quality monitoring stations use 1 h as the shortest interval for recording measurements. Thus, based on this average time, we could compare the concentrations used in the experiments and the measured environmental concentrations. In fact, the instillation protocols try to mimic in minutes (or less time) the exposure that would occur in hours, days, even months in environmental conditions.
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[^1]: EAP: environmental air PM, CAP: concentrated air PM.

[^2]: EAP: environmental air PM, CAP: concentrated air PM.

[^3]: These data are a compilation of results in our dataset, as presented in [Table 2](#tbl2){ref-type="table"}, [Table 3](#tbl3){ref-type="table"}. n: number of experiments, EAP: environmental air PM, CAP: concentrated air PM, SEM: standard error of the mean.
